Chemical compounds and their uses

JP2026520485APending Publication Date: 2026-06-23GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD +1

Patent Information

Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO 2) LTD
Filing Date
2024-05-31
Publication Date
2026-06-23

Smart Images

  • Figure 2026520485000001_ABST
    Figure 2026520485000001_ABST
Patent Text Reader

Abstract

A specific chemical compound of formula (I): This specification discloses chemical compounds useful for treating cancers, including cancers that are treatable by WRN inhibition, such as those characterized by microsatellite instability (MSI) and / or dysfunction of DNA mismatch repair (dMMR), and more particularly by inhibiting Werner syndrome ATP-dependent helicase enzyme (WRN) activity, and thus WRN helicase domain activity. Pharmaceutical compositions comprising such compounds, methods of using such compounds, and methods of preparing them are also disclosed.
Need to check novelty before this filing date? Find Prior Art